Pacira BioSciences Inc
PCRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.04B
Close$
$58.75
112.7% upside
Current Fair Value
112.7% upsideUndervalued by 112.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.04 Billion |
|---|---|
| Enterprise Value | $904.35 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.16 |
| Beta | 0.27 |
| Outstanding Shares | 40,461,000 |
Return
| Return on Equity | 5.68% |
|---|---|
| Return on Assets | 3.08% |
| Return on Invested Capital | 1.79% |
Valuation & Multiples
| P/E Ratio | 216.3 |
|---|---|
| PEG | 458.92 |
| Price to Sales | 1.53 |
| Price to Book Ratio | 1.73 |
| Enterprise Value to Revenue | 1.23 |
| Enterprise Value to EBIT | 46.03 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.65
Average shareholder expectationRevenue Estimate
$191.06 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.80
Average shareholder expectationRevenue Estimate
$188.86 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 61.14% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.21%▼ 98.37% |
|---|---|
| Total Invested | $43.22M▼ 95.61% |
| Investors Holding | 51▼ 192.00% |
ESG Score
No data